1. Home
  2. JYNT vs ELTX Comparison

JYNT vs ELTX Comparison

Compare JYNT & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.92

Market Cap

138.0M

Sector

Miscellaneous

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$13.08

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
ELTX
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
134.1M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
JYNT
ELTX
Price
$8.92
$13.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$17.00
$13.00
AVG Volume (30 Days)
44.3K
135.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.94
EPS
0.12
N/A
Revenue
$117,696,356.00
$2,301,000.00
Revenue This Year
$5.65
N/A
Revenue Next Year
$3.86
N/A
P/E Ratio
$76.42
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$4.60
52 Week High
$13.47
$12.62

Technical Indicators

Market Signals
Indicator
JYNT
ELTX
Relative Strength Index (RSI) 43.20 81.85
Support Level $8.25 $7.78
Resistance Level $10.47 N/A
Average True Range (ATR) 0.40 0.95
MACD -0.01 0.43
Stochastic Oscillator 44.80 92.41

Price Performance

Historical Comparison
JYNT
ELTX

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: